Marathon Capital Management Merck & Co., Inc. Transaction History
Marathon Capital Management
- $380 Million
- Q2 2024
A detailed history of Marathon Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Marathon Capital Management holds 32,064 shares of MRK stock, worth $3.65 Million. This represents 1.05% of its overall portfolio holdings.
Number of Shares
32,064
Previous 32,304
0.74%
Holding current value
$3.65 Million
Previous $4.26 Million
6.87%
% of portfolio
1.05%
Previous 1.05%
Shares
27 transactions
Others Institutions Holding MRK
# of Institutions
3,830Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$27.8 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$23.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.4 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.24 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.48 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $288B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...